Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$41,000.00

Molecular mechanisms of dendritic cell tolerogenic function

EF 2024-25

Résumé
Our research program is focused on understanding dendritic cell (DCs) biology, since DCs are the cornerstone in the induction of effective immunity and in the maintenance of immune tolerance. Depending on DC subset, the maturation state, the expression of specific costimulatory molecules and the cytokines produced, DCs can influence adaptive immune T cell response. These DC subsets express a unique set of transcription factors such as Stat5 and C/EBPß that regulate their development and function. We have reported that bone marrow derived tolerogenic DC (BMDC) exhibit higher levels of phosphorylation and enhanced DNA binding activity of C/EBPß that is regulated through the p38 MAPK/CREB axis suggesting that C/EBPß is a master regulator of BMDC tolerogenic phenotype and function. Since our last funding, we revealed an exciting new finding related to previously unknown mechanisms underlying DC tolerogenic phenotype and functions. We reported that BMDC expressing active form of Stat5b (Stat5b-CA), we named Stat5b.BMDCs, are tolerogenic and that Stat5b-CA induces DC tolerogenic function by modulating IRF4 and IRF8 expression through recruitment of a methyl transferase Ezh2. Our research program comprises 3 self-standing projects. Its long-term goal is to understand signaling pathways controlling DC differentiation and function, a fundamental process in DC biology that has essential role in modulating immune response outcome. Short-term objective is to investigate the role and mechanisms of STAT5b-C/EBPß axis in DC differentiation and function, a research area which remains completely unknown. Project 1) To investigate the contribution of Stat5b/C/EBPß axis in IRF4 and IRF8 regulation and tolerogenic DC differentiation and function. Gene and protein expression approaches as well shRNA technology and CEBPß-/-DCs will be used to examine role of C/EBPß on IRF4 and IRF8 expression and BMDC function. Project 2) To investigate the molecular mechanisms by which C/EBPß regulates IRF4 and IRF8 expression in tolerogenic and immunogenic DCs. Here, we will investigate the role of C/EBPß isoforms in regulating IRF4 and IRF8 expression and tolerogenic DC phenotype and function. Project 3) To investigate the role of Stat5b isoforms in DC differentiation and function and underlying mechanisms. We will use a reconstituted Luciferase assay system to analyze the ability of Stat5b isoforms to induce irf4 and irf8 gene activation. BMDCs (physiologic system) from mice lacking stat5 tetramers will be used to validate our data and the effect on their phenotype and function Impact: Understanding the mechanisms that control DC differentiation and tolerogenic function will improve our knowledge of basic immunology and may also help understanding how DCs shape adoptive immune response. Our research will strengthen Canadian science in immunology and consolidate the expertise and training of several students who will join the workforce in areas of science and engineering.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2024-04744
Name nom
Amrani, Abdelaziz
Department département
Pédiatrie - Pédiatrie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Molecular mechanisms of dendritic cell tolerogenic function
Keywords
dendritic cells,; signalling pathway,; pcr, dna, rna; cytokines; transcription factors
Application summary
Our research program is focused on understanding dendritic cell (DCs) biology, since DCs are the cornerstone in the induction of effective immunity and in the maintenance of immune tolerance. Depending on DC subset, the maturation state, the expression of specific costimulatory molecules and the cytokines produced, DCs can influence adaptive immune T cell response. These DC subsets express a unique set of transcription factors such as Stat5 and C/EBPß that regulate their development and function. We have reported that bone marrow derived tolerogenic DC (BMDC) exhibit higher levels of phosphorylation and enhanced DNA binding activity of C/EBPß that is regulated through the p38 MAPK/CREB axis suggesting that C/EBPß is a master regulator of BMDC tolerogenic phenotype and function. Since our last funding, we revealed an exciting new finding related to previously unknown mechanisms underlying DC tolerogenic phenotype and functions. We reported that BMDC expressing active form of Stat5b (Stat5b-CA), we named Stat5b.BMDCs, are tolerogenic and that Stat5b-CA induces DC tolerogenic function by modulating IRF4 and IRF8 expression through recruitment of a methyl transferase Ezh2. Our research program comprises 3 self-standing projects. Its long-term goal is to understand signaling pathways controlling DC differentiation and function, a fundamental process in DC biology that has essential role in modulating immune response outcome. Short-term objective is to investigate the role and mechanisms of STAT5b-C/EBPß axis in DC differentiation and function, a research area which remains completely unknown. Project 1) To investigate the contribution of Stat5b/C/EBPß axis in IRF4 and IRF8 regulation and tolerogenic DC differentiation and function. Gene and protein expression approaches as well shRNA technology and CEBPß-/-DCs will be used to examine role of C/EBPß on IRF4 and IRF8 expression and BMDC function. Project 2) To investigate the molecular mechanisms by which C/EBPß regulates IRF4 and IRF8 expression in tolerogenic and immunogenic DCs. Here, we will investigate the role of C/EBPß isoforms in regulating IRF4 and IRF8 expression and tolerogenic DC phenotype and function. Project 3) To investigate the role of Stat5b isoforms in DC differentiation and function and underlying mechanisms. We will use a reconstituted Luciferase assay system to analyze the ability of Stat5b isoforms to induce irf4 and irf8 gene activation. BMDCs (physiologic system) from mice lacking stat5 tetramers will be used to validate our data and the effect on their phenotype and function Impact: Understanding the mechanisms that control DC differentiation and tolerogenic function will improve our knowledge of basic immunology and may also help understanding how DCs shape adoptive immune response. Our research will strengthen Canadian science in immunology and consolidate the expertise and training of several students who will join the workforce in areas of science and engineering.